Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
about
RNA interference-based nanosystems for inflammatory bowel disease therapyRecent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseTransfer and functional consequences of dietary microRNAs in vertebrates: concepts in search of corroboration: negative results challenge the hypothesis that dietary xenomiRs cross the gut and regulate genes in ingesting vertebrates, but important qSTAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsNew aspects of gene-silencing for the treatment of cardiovascular diseasesGlycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle.Planar bioadhesive microdevices: a new technology for oral drug delivery.Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.Oral nucleic acid therapy using multicompartmental delivery systems.Characterization of cross-linked gelatin nanoparticles by electrophoretic techniques in the liquid and the gas phase.siRNA-mediated targeting of the RNA-dependent RNA polymerase in the Norovirus genome.Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.Regenerative medicine and cell-based approaches to restore pancreatic function.
P2860
Q28071518-4FC40710-6D36-4B82-BC95-7E54DED55DA8Q28073219-901A3952-0243-4015-9CF8-52DEDF7755AFQ33945339-C9910403-4150-4E26-A991-3508B1243056Q35031755-18BF88B1-6C77-405E-B224-73C3EB5226E6Q37277425-267EEEE2-1AC5-4493-B807-8BA31A25CA11Q37695146-D5B08CE0-8FE4-4A6E-81D9-91BEDFF25D4DQ38248999-3DD3C513-DDE2-4973-9769-8651E4077F93Q39170844-8E86D75E-831D-41E0-8E5E-0B91E0EA03D0Q39330117-BC98E98E-4FD9-4F58-84DF-003B76B537D8Q44774456-CB3A6C28-2961-4672-AB9D-CB95141F636CQ45750170-F7FA8F72-0482-4076-A96A-736278E6474FQ47754415-09FB1319-AE30-4DE4-B99C-A75BFCEDDB0BQ48120325-C9234797-B156-453B-9C26-B8F71F2226A9Q50268454-A288CFF0-252E-4C0B-B3B7-7C5166D96AA4Q52543005-1FC88C8D-F5EF-4655-9146-1D026C91A509
P2860
Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Multi-compartmental oral deliv ...... in the gastrointestinal tract.
@en
type
label
Multi-compartmental oral deliv ...... in the gastrointestinal tract.
@en
prefLabel
Multi-compartmental oral deliv ...... in the gastrointestinal tract.
@en
P2093
P1476
Multi-compartmental oral deliv ...... in the gastrointestinal tract.
@en
P2093
Christina Kriegel
Husain Attarwala
Mansoor Amiji
P304
P356
10.1016/J.ADDR.2012.11.003
P407
P577
2012-12-07T00:00:00Z